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Abstract
Background: Up to one-third of people affected by cancer experience ongoing psychological distress and would
benefit from screening followed by an appropriate level of psychological intervention. This rarely occurs in routine
clinical practice due to barriers such as lack of time and experience. This study investigated the feasibility of
community-based telephone helpline operators screening callers affected by cancer for their level of distress using
a brief screening tool (Distress Thermometer), and triaging to the appropriate level of care using a tiered model.
Methods: Consecutive cancer patients and carers who contacted the helpline from September-December 2006 (n
= 341) were invited to participate. Routine screening and triage was conducted by helpline operators at this time.
Additional socio-demographic and psychosocial adjustment data were collected by telephone interview by
research staff following the initial call.
Results: The Distress Thermometer had good overall accuracy in detecting general psychosocial morbidity
(Hospital Anxiety and Depression Scale cut-off score ≥ 15) for cancer patients (AUC = 0.73) and carers (AUC = 0.70).
We found 73% of participants met the Distress Thermometer cut-off for distress caseness according to the Hospital
Anxiety and Depression Scale (a score ≥ 4), and optimal sensitivity (83%, 77%) and specificity (51%, 48%) were
obtained with cut-offs of ≥ 4 and ≥ 6 in the patient and carer groups respectively. Distress was significantly
associated with the Hospital Anxiety and Depression Scale scores (total, as well as anxiety and depression
subscales) and level of care in cancer patients, as well as with the Hospital Anxiety and Depression Scale anxiety
subscale for carers. There was a trend for more highly distressed callers to be triaged to more intensive care, with
patients with distress scores ≥ 4 more likely to receive extended or specialist care.
Conclusions: Our data suggest that it was feasible for community-based cancer helpline operators to screen
callers for distress using a brief screening tool, the Distress Thermometer, and to triage callers to an appropriate
level of care using a tiered model. The Distress Thermometer is a rapid and non-invasive alternative to longer
psychometric instruments, and may provide part of the solution in ensuring distressed patients and carers affected
by cancer are identified and supported appropriately.
Background
Cancer diagnosis and treatment is a significant life stres-
sor resulting in psychological, social, physical and spiri-
tual difficulties for both cancer patients and their carers
[1-6]. Approximately 30% of cancer patients report
ongoing clinically significant distress [5,7-9]. Although
psychological intervention can reduce patient distress
and improve quality of life [10], health professionals
often fail to diagnose distress [9]. Barriers to health pro-
fessionals detecting and referring cancer patients include
al a c ko ft i m ea n ds e l f - c o n f i d e n c eo re x p e r i e n c ei n
investigating distress and in using psychometric instru-
ments [11]. As well, 10 to 50 percent of carers suffer
from ongoing psychological morbidity [4]. Carers tend
to be more focused on the patient’s needs, are less likely
to disclose their concerns, and only half of those with
serious psychological distress seek help [2,4]. * Correspondence: Anna.Hawkes@gmail.com
1Viertel Centre for Research in Cancer Control, Cancer Council Queensland,
PO Box 201, Spring Hill, Queensland, 4004, Australia
Hawkes et al. BMC Cancer 2010, 10:14
http://www.biomedcentral.com/1471-2407/10/14
© 2010 Hawkes et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Cancer-specific telephone helplines provide a unique
opportunity to screen callers for distress and they have
been available throughout North America, Europe, the
United Kingdom, Australia and other developed coun-
tries for over twenty years [12-14]. Cancer Council
Helpline is an Australian telephone information/support
service operated from the state-based Cancer Councils
(non-government charitable organisations). The service
is staffed by health professionals experienced in oncol-
ogy, and provides cancer-specific information and prac-
tical support to those affected by cancer both over the
phone and in mailed written materials [12,13]. Being
tele-based, it can assist individuals who may not other-
wise be reached due to geographical boundaries, poor
health, or transportation issues [14,15]. In Queensland,
Australia, Cancer Council Helpline services residents
across the state of Queensland. On average, the service
receives approximately 190 calls per week from cancer
patients or carers and their most common requests
include health-related information/resources, practice
advice, and emotional support. During the current
study, Cancer Council Helpline in Queensland incorpo-
rated the Distress Thermometer (DT) and associated
Problem List (PL) [16] into routine screening protocol
for cancer patients and carers. The DT is a rapid, non-
invasive, acceptable, and valid alternative to longer psy-
chometric instruments [17] and may provide part of the
solution in ensuring distressed patients and carers are
identified and supported appropriately. The PL identifies
possible contributing factors, summarised into five cate-
gories: practical, family, emotional, spiritual, and physi-
cal. A recent meta-analysis found the DT demonstrated
77.1% sensitivity and 66.1% specificity to detect cancer-
related distress, and 80.9% sensitivity and 60.2% specifi-
city to detect depression [18]. The DT is comparable to
more rigorous and comprehensive criterion measures,
including the Hospital Anxiety and Depression Scale
(HADS) [17,19-25]. A cut-off score of four on the DT
yields optimal sensitivity and specificity in comparison
with “caseness,” as established by the HADS [22,23,26].
This cut-off has also identified patients reporting high
levels of physical, emotional, practical, and family pro-
blems [27-29]. In previous studies, approximately
27-62% of cancer patients have met this cut-off
[20,22,23,25,26,29,30]. The DT has been used in hospital
and clinical contexts across a range of cancer diagnoses
[16,21,22,25,29,31-34], however there are no studies that
have evaluated the measure’s utility in a community-
based helpline setting.
Further, few studies have investigated the use of the
DT with carers. In a recent study, oncology outpatients
were asked to distribute a questionnaire to “the indivi-
dual they designated as the family member closest to
them during the course of their disease” [6]. The DT
exhibited good diagnostic utility relative to the HADS
[area under the curve or AUC = 0.88 relative to the
HADS anxiety subscale (HADS-A) and 0.84 relative to
the HADS depression subscale (HADS-D)]. A cut-off of
four to five maximised sensitivity (86.2% HADS-A;
88.2% HADS-D) and specificity (71.2% HADS-A; 67.6%
HADS-D). Just over 47% of those surveyed scored over
t h ec a s et h r e s h o l d[ 6 ] .T h eD Th a sa l s ob e e nu s e dt o
screen carers of patients with advanced malignancies,
and reported high levels of distress, both before (mean
= 6.96, s.d. = 3.24) and after surgery (mean = 5.83, s.d.
= 2.29) [35].
An extension of the screening process is to match the
level and nature of client distress to appropriate sources
of care [36,37], a process that rarely occurs in routine
clinical practice [36]. There is also limited information
on the effect of distress screening on longer term func-
tional or psychosocial outcomes. The Cancer Council
Queensland has developed a tiered intervention model
where callers are triaged to one of five levels of increas-
ingly intensive psycho-social care based on their DT
score and the operator’sc l i n i c a lj u d g e ment [37]. Again
there is limited literature addressing the role of the DT
and PL in client referral, and the few studies that have
addressed referral have been largely descriptive. Studies
indicate the instrument is accepted and perceived as
helpful by healthcare workers. Two studies in cancer
clinics found the DT and PL promoted communication
between the patient and health care team, helped direct
or prioritise interventions and referrals [38,39], and did
not substantially burden the clinic or referral agencies
[39]. Patient responses to the PL have been used for
“intuitive rather than evidence based” service provision
including: social services for practical or psychosocial
problems; pastoral care for spiritual; nutritional, rehabili-
tation or symptom management for physical problems
[40].
Further studies report on the validity of referrals based
on DT cut-off. Prostate cancer patients with a DT cut-
off of five were referred for psychiatric assessment, with
47% of participants meeting criteria for a DSM-IV disor-
der (i.e., adjustment disorder with mixed features of
anxiety and depression, major depression in partial
remission, and three had depression related to medica-
tion or their medical condition) [16]. Another study
referred breast cancer patients after first recurrence with
a DT greater than the cut-off score (or those with a
score less than the cut-off who requested follow-up) to
a three-month individually-tailored intervention, and
found the intervention significantly reduced the rate of
psychiatric disorders [40,41].
To our knowledge there has been no previous report
on the feasibility of distress screening using valid instru-
ments for callers to a community-based cancer helpline.
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may provide an opportunity to reach and support dis-
tressed individuals, particularly carers, not always identi-
fied in a clinical setting. Also, although the DT has been
shown to be valid for distress screening amongst cancer
patients, there has been limited research addressing dis-
tress screening in routine clinical practice for carers. For
the first time, the current study aims to investigate the
feasibility of detecting psychosocial morbidity for cancer
patients and carers using the DT, followed by appropri-
ate referral, in a community-based telephone helpline
setting.
Methods
Participants and Recruitment
Consecutive inbound Cancer Helpline callers were
invited to participate from September-December 2006.
Eligible participants were: diagnosed cancer patients or
carer/support people for a diagnosed cancer patient,
over 18 years old, and English-speaking. Carers/support
persons included immediate family members, relatives/
friends that were involved in the care of a diagnosed
cancer patient (hereafter referred to as ‘carers’). Partici-
pants were recruited to the study by Cancer Helpline
operators by providing verbal informed consent during
the initial call.
Data Collection
Operators asked all cancer patients and carers about
their level of distress (using the DT [16]) during their
initial call (’On a scale of zero to 10 how much distress
have you been experiencing in the past week including
today?’). Consenting participants in the study were then
contacted by the research team as soon as possible after
the initial call (within 30 days) to complete a 20 minute
telephone interview to collect additional data. Additional
data included: socio-demographics; cancer information;
and anxiety and depression (HADS) [42]. Distress (DT)
was recorded again at this time, as a control measure, to
determine whether distress levels remained constant
during the interval between the initial call and
researcher follow-up. There were no significant differ-
ences in median distress levels measured at the two
time-points for cancer patients or carers (Wilcoxon
signed ranks test, p ≥ 0.20). To investigate selection
bias, de-identified aggregate demographic data and base-
line distress level were recorded for non-participating
callers (i.e., callers who did not agree to participate in
the study). There were no significant differences in age
and gender between participants and non-participants.
However, cancer patients were significantly more likely
to participate than carers (59.9% vs 42.9%, c
2 = 18.4, df
= 1, p < 0.001). There was also no statistical difference
between participants and non-participants in terms of
proportions meeting the distress cut-off. However there
was a substantial proportion of missing data for DT rat-
ings for non-participants (33.6%).
Measures
Socio-demographics and Cancer Information
Socio-demographic questions included gender, age, mar-
ital status, education level, and employment status. Par-
ticipants were also asked what cancer diagnosis they (or
their significant other) had received and the date of
diagnosis, as well as treatments they had received for
their cancer.
Distress
D i s t r e s sw a sm e a s u r e du s i n gt h eD T[ 1 6 ] ,as i n g l ei t e m
11-point scale (0-no distress to 10-extreme distress) in a
thermometer format used to rate level of distress. The
associated PL asks respondents to respond to 34 items
was modified to utilise over the telephone. This study
asked respondents to respond only to the specified cate-
gories (practical, family, emotional, spiritual/religious,
and physical problems) rather than the individual items
within each category. For instance, “Have practical pro-
blems such as housing, finances, work, transport, or
child care been a cause of your distress in the past week
including today?” Helpline operators were trained to
administer the DT and PL by qualified psychologists
and they received regular in-services.
Anxiety and Depression
The HADS [42] contains 2 7-item subscales measuring
anxiety (HADS-A) and depression (HADS-D). Each item
is scored on a 4-point scale (0-3) resulting in a score
ranging from 0-21 for each subscale. Subscale scores 0-7
classify participants as non-cases, 8-10 indicates border-
line cases, and scores ≥ 11 indicate clinical levels. Total
HADS scores (HADS-T) ≥ 15 indicate clinically signifi-
cant distress. Studies have used the HADS as a criterion
measure to validate the DT among cancer patients
[19,20,23,25,26,37]. It has also been used to measure
psychological distress among family members of cancer
patients [6].
Tiered Model of Care
Operators triaged participants, utilising their DT score
and the clinical judgement of operators, to the appropri-
ate level of care using a tiered model of care [37]. The
levels of care and corresponding DT score included: (i)
Universal Care (information and advice; DT score of
0-3); (ii) Supportive Care (psycho-education, emotional
support and/or triage; DT score of 0-3); (iii) Extended
Care (focused counselling with psycho-education and
coping skills training; DT score of 4-8); (iv) Specialist
Care (narrow focus with skilled therapist; DT score of
4-8); and (v) Acute Care (broad focus, specialist services
or multidisciplinary team; DT score of 9-10).
Data Analysis
Descriptive analyses included frequencies, percentages,
means and standard deviations, medians and
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the characteristics of the study sample (socio-demo-
graphics and cancer information), anxiety and depres-
sion (HADS), distress (DT and PL) and triage (level of
care). Receiver operating characteristic (ROC) analysis
was used to evaluate the diagnostic accuracy of the DT
to detect cases identified by the HADS. A series of
ROC curves were created using the different DT cut-
off scores on the clinical cut-off score of the HADS-T
(≥ 15) and HADS-A and HADS-D (≥ 8) in order to
measure the sensitivity and specificity values in discri-
minating cases as identified with the HADS. Differ-
ences between cancer patients and carers for
demographics, cancer information, anxiety, depression
and distress were analysed with t-tests, Mann-Whitney
U-tests and chi-square analyses. The associations
between participant characteristics and DT, DT and
HADS, Problem List and level of care were assessed
using chi-square analyses. Participant characteristics
significantly associated with distress (p < 0.05) were
entered into a multivariate logistic regression model to
assess relative contributions. Quantitative data were
analysed using the ‘Statistical Package for Social
Sciences’ (SPSS) 14.0 for Windows.
Ethics
Approval was received from the Griffith University
Human Research Ethics Committee.
Results
Response Rate
From September to December 2006, 341/648 (52.6%)
Cancer Helpline callers provided informed consent to
participate. Reasons for non-participation included: 162
(25.0%) refusals; 40 (6.2%) callers were not asked to
participate by operators; 53 (8.2%) callers had missing
data related to their reason for refusal (indicating they
refused or were not asked to participate by the opera-
tor); 49 (7.6%) did not complete the additional data
collection within 30 days; and three (0.5%) callers died
before the additional data collection took place.
Participants
The majority of callers were: cancer patients (65.4%);
women (76.2%); employed (41.4%) or retired (31.5%);
and married or in a de-facto relationship (61.2%).
Mean age was 55.9 years (SD = 12.9 years). Just over
60% (61.9%) reported senior high school, trade or tech-
nical certificate, or university as their highest level of
education. Compared with cancer patients, carers were
more likely to be younger (t = -4.2, df = 338, p <
0.001) and female (89.0% versus 69.5%, c
2 = 16.2, df =
1, p < 0.001). Carers were also more likely to be
employed casual part-time (13.7% versus 4.9%) or be
involved full time in home duties/caring (22.2% versus
7.2%) and less likely to be unemployed/looking for
T
a
b
l
e
1
S
e
n
s
i
t
i
v
i
t
y
a
n
d
s
p
e
c
i
f
i
c
i
t
y
a
t
e
a
c
h
c
u
t
-
o
f
f
p
o
i
n
t
o
n
t
h
e
D
i
s
t
r
e
s
s
T
h
e
r
m
o
m
e
t
e
r
(
D
T
)
[
1
6
,
1
9
]
f
o
r
t
h
e
c
r
i
t
e
r
i
o
n
m
e
a
s
u
r
e
,
H
o
s
p
i
t
a
l
A
n
x
i
e
t
y
a
n
d
D
e
p
r
e
s
s
i
o
n
S
c
a
l
e
(
H
A
D
S
)
[
4
2
]
f
o
r
c
a
n
c
e
r
p
a
t
i
e
n
t
s
a
n
d
c
a
r
e
r
s
.
H
A
D
S
T
o
t
a
l
S
c
o
r
e
(
≥
1
5
)
H
A
D
S
A
n
x
i
e
t
y
S
u
b
s
c
a
l
e
(
≥
8
)
H
A
D
S
D
e
p
r
e
s
s
i
o
n
S
u
b
s
c
a
l
e
(
≥
8
)
C
a
n
c
e
r
P
a
t
i
e
n
t
C
a
r
e
r
C
a
n
c
e
r
P
a
t
i
e
n
t
C
a
r
e
r
C
a
n
c
e
r
P
a
t
i
e
n
t
C
a
r
e
r
D
T
c
u
t
-
o
f
f
S
e
n
s
i
t
i
v
i
t
y
S
p
e
c
i
f
i
c
i
t
y
S
e
n
s
i
t
i
v
i
t
y
S
p
e
c
i
f
i
c
i
t
y
S
e
n
s
i
t
i
v
i
t
y
S
p
e
c
i
f
i
c
i
t
y
S
e
n
s
i
t
i
v
i
t
y
S
p
e
c
i
f
i
c
i
t
y
S
e
n
s
i
t
i
v
i
t
y
S
p
e
c
i
f
i
c
i
t
y
S
e
n
s
i
t
i
v
i
t
y
S
p
e
c
i
f
i
c
i
t
y
≥
0
1
0
0
.
0
0
.
0
1
0
0
.
0
0
.
0
1
0
0
.
0
0
.
0
1
0
0
.
0
0
.
0
0
1
0
0
.
0
0
.
0
1
0
0
.
0
0
.
0
≥
1
9
6
.
8
1
1
.
1
9
6
.
5
1
2
.
2
9
4
.
6
8
.
8
≥
2
9
5
.
8
1
5
.
1
1
0
0
.
0
5
.
2
9
5
.
6
1
6
.
8
1
0
0
.
0
7
.
3
9
1
.
9
1
1
.
6
9
7
.
3
2
.
6
≥
3
9
3
.
7
3
2
.
5
9
6
.
4
8
.
6
9
3
.
0
3
6
.
5
9
5
.
9
9
.
8
8
9
.
2
2
6
.
5
9
4
.
6
6
.
5
≥
4
8
3
.
2
5
0
.
8
9
4
.
6
1
3
.
8
8
1
.
6
5
5
.
1
9
5
.
9
1
9
.
5
7
8
.
4
4
3
.
5
9
1
.
9
1
0
.
4
≥
5
8
0
.
0
5
7
.
1
9
1
.
1
1
7
.
2
7
8
.
1
6
1
.
7
9
3
.
2
2
4
.
4
7
5
.
7
4
9
.
7
8
6
.
5
1
3
.
0
≥
6
6
2
.
1
7
1
.
4
7
6
.
8
4
8
.
3
5
9
.
7
7
4
.
8
8
0
.
8
6
5
.
9
5
6
.
8
6
4
.
0
6
4
.
9
3
6
.
4
≥
7
4
9
.
5
8
1
.
0
6
0
.
7
6
5
.
5
5
0
.
9
8
7
.
9
6
3
.
0
8
0
.
5
3
9
.
2
7
1
.
4
5
1
.
4
5
4
.
6
≥
8
3
1
.
6
8
7
.
3
5
0
.
0
8
6
.
2
3
3
.
3
9
2
.
5
4
8
.
0
9
7
.
6
2
8
.
4
8
3
.
0
5
1
.
4
7
7
.
9
≥
9
1
6
.
8
9
5
.
2
1
7
.
9
9
8
.
3
1
6
.
7
9
7
.
2
1
3
.
7
9
7
.
6
1
3
.
5
9
1
.
8
2
1
.
6
9
6
.
1
≥
1
0
9
.
5
9
7
.
6
5
.
4
1
0
0
.
0
9
.
7
9
9
.
1
4
.
1
1
0
0
.
0
8
.
1
9
5
.
9
8
.
1
1
0
0
.
0
>
1
0
0
.
0
1
0
0
.
0
0
.
0
1
0
0
.
0
0
.
0
1
0
0
.
0
0
.
0
1
0
0
.
0
0
.
0
1
0
0
.
0
0
.
0
1
0
0
.
0
Hawkes et al. BMC Cancer 2010, 10:14
http://www.biomedcentral.com/1471-2407/10/14
Page 4 of 10work/permanently ill/disabled/unable to work (7.7% ver-
sus 18.4%) or retired (21.4% versus 36.8%) (c
2 =3 5 . 1 ,
df = 5, p < 0.001).
The most commonly reported cancer types were breast
(31.4%) and prostate cancer (18.2%). Cancer patients
were significantly more likely to report a breast cancer
diagnosis than carers (43.0% versus 21.4%, c
2 = 15.7,
df = 1, p < 0.001). Carers were more likely to report lung
(15.4% versus 7.6%, c
2 = 5.0, df = 1, p = 0.03), liver
(12.0% versus 3.6%, c
2 = 8.9, df = 1, p = 0.003), or brain
(8.5% versus 1.8%, c
2 = 8.9, df = 1, p = 0.003) cancer
diagnoses. The median time since diagnosis was 2.0
months (IQR = 9.0) and there was no statistical differ-
ence between cancer patients and carers. Approximately
40% (41.8%) of callers indicated that they, or the cancer
patient they cared for, had undergone surgery in the last
6 months. Further, over the last 6 months, chemotherapy,
radiation and hormone therapy had commenced for
24.0%, 11.5%, and 6.3% of the total sample, respectively.
Also, cancer patients were significantly more likely to
report commencing chemotherapy within the last 6
months, compared to carers (27.4% versus 17.4%; c
2 =
4.1, df = 1, p = 0.04).
Psychosocial Adjustment
Diagnostic Accuracy of the DT
ROC demonstrated the optimal cut-off score on the DT
in identifying caseness according to the HADS-T cut-off
(≥ 15) and HADS-A and HADS-D cut-offs (≥ 8). Sensi-
tivity and specificity at each DT cut-off are presented in
Table 1, and ROC curves are graphed in Figure 1. For
cancer patients, the area under the curve (AUC) was
0.73 (95% CI 0.66-0.80) with a DT cut-off ≥ 4m a x i m i s -
ing sensitivity and specificity in detecting general psy-
chosocial morbidity (HADS-T score ≥ 15). This was also
a reasonable cut-off for HADS-A and HADS-D. For
carers, the AUC was 0.70 (95% CI 0.61-0.80), and a cut-
off of ≥ 6 maximised sensitivity and specificity for the
criterion measure, HADS-T. Again this was a reasonable
cut-off for anxiety and depression subscales. A cut-off ≥
4 for carers increased sensitivity to over 94% but low-
ered specificity to less than 14%. The DT was more
accurate in predicting HADS-A than HADS-D for can-
cer patients and carers. For patients, the respective AUC
values were 0.76 (95% CI: 0.70-0.82) and 0.63 (95% CI:
0.55-0.71) using HADS-A and HADS-D criterion mea-
sures, respectively. For carers, the AUC was 0.80 (95%
CI: 0.72-0.88) and 0.60 (95% CI: 0.47-0.72), using
HADS-A and HADS-D subscales as criterion measures.
Distress
Median distress was 6.00 (IQR = 4), with carers report-
ing higher levels than patients (z = -4.2, p < 0.001). The
majority of participants met the DT cut-off ≥ 4 (72.8%),
although patients were more likely to fall below the cut-
off compared with carers (Table 2). Participants
reported emotional problems as their main cause of dis-
tress (Table 2). Carers were significantly more likely to
report family and emotional concerns than cancer
patients, and patients were more likely to report treat-
ment concerns than carers. A large proportion of parti-
cipants (27.6%) reported “other” concerns; that is,
concerns that could not be coded into any of the five
PL categories. The most common concerns identified in
the ‘other’ option related to decision-making support or
request for further information.
Participant Characteristics Associated With Distress
At the bivariate level: female gender (c
2 = 5.68, df = 1, p
= 0.017); younger age-group (c
2 =2 2 . 7 ,d f=4 ,p<
0.001); current employment (c
2 = 14.0, df = 5, p =
0.016); higher household income (although persons with
an income of $60,000 per annum to less than $80,000
Figure 1 Area under the receiver operator characteristic (ROC) curve for the criterion measures. (a) Hospital Anxiety and Depression Scale
[42] total score (≥ 15), (b) Hospital Anxiety and Depression Scale anxiety subscale (≥ 8), and (c) Hospital Anxiety and Depression Scale depression
subscale (≥ 8).
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Page 5 of 10indicated higher levels of distress than those on $80,000
or more; c
2 = 10.4, df = 4, p = 0.034); and carer vs can-
cer patient (c
2 = 26.8, df = 1, p < 0.001) were signifi-
cantly associated with reporting a distress level of ≥ 4a t
Time 1. Participant characteristics including ethnicity,
health cover, country of birth, education and marital sta-
tus were not significantly related to level of distress (p >
0.05). Cancer related variables including months since
diagnosis and type of treatment were also unrelated to
distress levels (p > 0.05). However, multivariate analysis
revealed that type of caller was the only variable that
maintained a statistically significant association with
level of distress with carers nearly 4 times more likely to
report a distress level of ≥ 4 (Table 3).
Anxiety and Depression
Approximately 56% and 33% of participants scored
above the HADS-A and HADS-D cut-off (≥ 8),
respectively (see Table 2 for patient and carer break-
downs). Compared with cancer patients, carers were
more likely to be anxious. However there were no differ-
ences between carers and patients in terms of depres-
sion status. Just under half (45.2%) of participants
reached the HADS-T clinical cut-off ≥ 15 and there was
no statistical difference between carers and cancer
patients.
Associations with DT
A greater proportion of family, emotional, and other
problems were associated with a DT cut-off ≥ 4i nc a n -
cer patients (Table 4). For carers, emotional problems
were associated with increased distress. However, only a
small proportion of carers fell below the distress cut-off
leading to small cell sizes, hence chi-square comparisons
for this group need to be interpreted with caution. Fall-
ing above the DT cut-off was strongly associated with
Table 2 Level of distress and associated problem list category [16,19], level of anxiety and depression[42], and level
of care cancer patients and carers were triaged to by Cancer Council Helpline operators[37].
Cancer Patient Carer
n%
1 n % p-value
DT cut-off
2 <0.001
Below cut-off (<4) 80 36.2 11 9.6
Above cut-off (≥ 4) 141 63.8 103 90.4
Problem List Category
Practical 53 23.8 32 27.1 0.50
Family 27 12.1 32 27.1 <0.001
Emotional 115 51.6 84 71.2 <0.001
Spiritual 3 1.3 2 1.7 0.80
5
Treatment 83 37.2 28 23.7 0.01
Symptoms 21 9.4 15 12.7 0.35
Other 61 27.4 33 28.0 0.90
HADS: Anxiety
3 0.03
Normal 108 48.4 42 35.6
Borderline 50 22.4 26 22.0
Clinical 65 29.1 50 42.4
HADS: Depression
3 0.68
Normal 147 65.9 80 67.8
Borderline 42 18.8 24 20.3
Clinical 34 15.2 14 11.9
HADS cut-off 0.28
5
Below cut-off (<15) 127 57.0 60 50.8
Above cut-off (≥ 15) 96 43.0 58 49.2
Level of Care triaged to
2,4 0.15
5
Universal 59 27.7 21 19.1
Supportive 111 52.1 69 62.7
Extended 43 20.2 19 17.3
Specialist 0 0.0 1 0.9
Acute 0 0.0 0 0.0
1. All percentages are valid percentages (i.e., missing values are excluded from the denominator).
2. Missing values: Distress level -1.8%; Level of Care-5.3%.
3. Anxiety and Depression subscales: Normal = score of 0-7; Borderline = score of 8-10; Clinical = score of 11+.
4. Extended, specialist and acute care categories were collapsed for chi-square comparisons.
Greater than 20% of cells have expected count less than 5 and/or minimum expected count is less than 1. Interpret with caution.
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patients, and increasing depression for patients (Table
4). Again, chi-square comparisons for carers need to be
interpreted with caution. Cancer patients with a DT ≥ 4
were significantly more likely to score ≥ 15 (overall cut-
off) on the HADS-T. This trend was also observed for
carers but the association was not significant.
Psychosocial Intervention
Tiered Model of Care
Table 2 includes the level of care callers were triaged to
when they called Cancer Helpline. The majority of call-
ers (80.5%) received Universal Care or Supportive Care.
Almost 20% were triaged to Extended Care. Only one
participant was directed to Specialist Care, and no call-
ers required Acute Care. Collapsing Extended, Specialist
and Acute care, there were no significant differences
between cancer patients and carers in terms of level of
care received.
Association between Distress and Level of Care
Table 4 outlines the association between level of distress
and level of care. Patients above DT cut-off ≥ 4w e r e
more likely to receive extended or specialist care. The
association between distress and level of care was not
significant in the carer sample although there was a
trend for highly distressed callers to be triaged to more
intensive care. The chi-square associations in the carer
sample were compromised by small cell sizes and must
be interpreted with caution.
Discussion
Study results indicate that a high proportion of Cancer
Helpline callers (64% of cancer patients and 90% of
carers) were distressed (DT ≥ 4); and Cancer Helpline
presents a unique and feasible opportunity to screen
cancer patients and carers for distress using the DT and
to triage callers to an appropriate level of care.
The proportion of distressed cancer patients (64%)
was consistent with the literature, albeit at the higher
end of reported rates [23,26,30]. However, the propor-
tion of distressed carers (90%) was considerably greater
than previously reported (47%) [6], which may be
e x p l a i n e db yt h es t u d yc o n t e xt. Previous investigators
Table 3 Distress (score of 4 or higher on the Distress Thermometer)[16,19] by participant characteristics for Cancer
Council Helpline callers.
Proportion distressed
Characteristic n % Adjusted OR 95% CI p-value
Type of Caller 0.001
Carer 103 90.4 3.90 1.78-8.57
Cancer Patient 141 63.8 1.00 Reference
Gender 0.52
Female 194 76.1 1.25 0.64-2.45
Male 50 62.5 1.00 Reference
Age-group 0.09
<40 years 37 90.2 3.08 0.70-13.54
40-49 years 49 84.5 3.12 0.83-11.80
50-59 years 64 66.7 1.15 0.39-3.40
60-69 years 68 74.7 2.02 0.86-4.78
70+ years 25 52.1 1.00 Reference
Work status 0.54
Employed full-time 48 77.4 1.07 0.34-3.33
Employed part-time 36 73.5 1.12 0.34-3.68
Employed casual part-time 23 85.2 1.70 0.40-7.24
Home duties or carer 33 80.5 0.96 0.30-3.06
Unemployed
1 40 80.0 2.42 0.85-6.85
Retired 63 60.0 1.00 Reference
Household income 0.22
<$20,000 44 62.9 0.46 0.15-1.40
$20,000 to <$40,000 64 68.8 0.45 0.16-1.26
$40,000 to <$60,000 41 70.7 0.46 0.16-1.30
$60,000 to <$80,000 23 92.0 2.16 0.40-11.74
$80,000 + 36 81.8 1.00 Reference
1. Unemployed group includes those looking for work, permanently ill, disabled or unable to work.
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tres [6], whilst one might expect Cancer Helpline callers
to be more distressed given they contacted the service
for assistance. In addition, consistent with earlier find-
ings [43,44], investigation of the association between
participant characteristics and distress revealed that
carers suffered from higher levels of distress than cancer
patients. In particular, we found that carers were signifi-
cantly more likely to identify emotional and family pro-
blems compared with the patient group, which may
have contributed to their higher levels of distress.
ROC analyses revealed that a DT cut-off score ≥ 4h a d
optimal sensitivity (83%) and specificity 51%) for cancer
patients relative to the HADS-T cut-off score, which has
been reported previously [17,22]. In comparison, a DT
cut-off ≥ 6 provided optimal sensitivity (77%) and specifi-
city (48%) for carers. A cut-off ≥ 4 for carers, increased
sensitivity to over 94%, but reduced specificity to less than
14%. Although maintaining a cut-off of ≥ 4 for carers
would increase the number of false positives, it would also:
ensure consistency across patient and carer groups; create
less confusion for Cancer Helpline staff; and increase the
sensitivity to detect distressed carers, a group that is less
likely to present with psychological symptoms [2,4].
The DT displayed good overall accuracy with ROC
curve analyses yielding AUC estimates relative to the
HADS-T cut-off score (≥ 0.70). This is consistent with
earlier findings [16,17,22,33]. However, AUC estimates
for the HADS subscales indicated poor DT score discri-
minatory power relative to the HADS-D. Further, a DT
cut-off ≤ 4 did not correlate with HADS-D in the carer
group. Some studies have indicated moderate to high
correlations between DT score and both HADS sub-
scales [6,23], however there is evidence to suggest that
the DT may not adequately detect depression [17,34].
Although the HADS is a well-validated measure of
depression and anxiety, some researchers have suggested
that distress is a more complicated concept. Trask et al.
(2002) found that the HADS-T accounted for less than
20% of the variability of “distress” as measured by the
Table 4 Associations between level of distress (Distress Thermometer, DT) and problem list categories [16,19], anxiety,
depression (Hospital Anxiety and Depression Scale, HADS) [42], and level of care cancer patients and carers were
triaged to (Tiered Model of Care) [37] by Cancer Council Helpline operators.
Cancer Patient Carer
DT score
<4
DT score
≥ 4
DT score
<4
DT score
≥ 4
n% n% p-value n% n% p-value
Problem List Category
Practical 15 18.8 37 26.2 0.21 3 27.3 26 25.2 0.88
3
Family 4 5.0 23 16.3 0.01 3 27.3 28 27.2 1.00
3
Emotional 25 31.3 89 63.1 <0.001 5 45.5 76 73.8 0.05
3
Spiritual 1 1.3 2 1.4 0.92
3 0 0.0 2 1.9 0.64
3
Treatment 24 30.0 58 41.1 0.10 4 36.4 23 22.3 0.30
3
Symptoms 5 6.3 16 11.3 0.21 2 18.2 13 12.6 0.60
3
Other 12 15.0 48 34.0 0.002 2 18.2 30 29.1 0.44
3
HADS: Anxiety
1,2 <0.001 0.008
3
Normal 59 73.8 48 34.0 8 72.7 33 32.0
Borderline 13 16.3 37 26.2
Clinical 8 10.0 56 39.7 3 27.3 70 68.0
HADS: Depression
1,2 0.005 0.70
3
Normal 64 80.0 83 58.9 8 72.7 69 67.0
Borderline 8 10.0 33 23.4
Clinical 8 10.0 25 17.7 3 27.3 34 33.0
HADS cut-off <0.001 0.13
< 15 64 80.0 62 44.0 8 72.7 50 48.5
≥ 15 16 20.0 79 56.0 3 27.3 53 51.5
Level of Care Triaged to <0.001 0.25
3
Universal 35 46.7 23 16.9 3 30.0 18 18.8
Supportive 36 48.0 74 54.4 7 70.0 58 60.4
Extended-Acute 4 5.3 39 28.7 0 0.0 20 20.8
1. Anxiety and Depression subscales: Normal = score of 0-7; Borderline = score of 8-10; Clinical = score of 11+.
2. Borderline and clinical categories have been collapsed for chi-square comparisons.
Greater than 20% of cells have expected counts less than 5 and/or the minimum expected count is less than 1. Interpret with caution.
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not significantly correlate with DT ratings. Another
study, utilising the Patient Health Questionnaire 9-Item
Depression Module as the criterion measure found that
a DT cut-off ≥ 7 was required to detect depression [21].
DT scores were associated (although not significant
for carers) with level of care referrals and HADS-T
scores indicating that the DT was useful for triaging to
the appropriate level of care. Requesting a DT rating
was standard protocol for Cancer Helpline operators
during the study. However, 30% of callers who did not
participate in the study were not asked to provide a dis-
tress rating by the helpline operator. This may indicate
that the operators were having difficulty utilising the
DT, or the DT was considered inappropriate in particu-
lar situations. As such, ongoing training and support for
Cancer Helpline operators is important in the imple-
mentation of distress screening instruments.
Study limitations included: (i) a 53% response rate,
with carers less likely to respond than cancer patients,
which may influence the generalisability of these results
particularly in a carer population; (ii) self-reported data
which limited our ability to collect clinical information
(eg. cancer stage) and make comparisons with study
data; (iii) the high proportion of carers reaching the DT
cut-off ≥ 4, relative to those below the cut-off which
made statistical comparisons unstable; (iv) HADS data
was collected up to 30 days after the DT score was col-
lected which may have impacted on the correlation
between the two instruments. However statistical testing
indicated no difference in median distress levels mea-
sured at the two time-points; and (v) the use of HADS
as the only criterion measure, as there is some contro-
versy over the appropriateness of this measure in asses-
sing psychopathology in palliative populations and
women with early breast cancer [20].
Conclusion
For patients and carers affected by cancer, distress is preva-
lent but often under-recognized and under-treated. The
results of this study suggest that a brief screening instru-
ment, the DT, can be incorporated into a community-
based telephone helpline to prospectively and rapidly iden-
tify cancer patients and carers with elevated levels of dis-
tress. However, further research is required to better
understand the ability of the DT in identifying depression.
Brief distress screening by a community-based cancer help-
line may help to bridge the treatment gap and ensure that
people who are distressed by a diagnosis of cancer are iden-
tified and receive the appropriate level of supportive care.
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